About Adaptilens
The Adaptilens A-IOL recaptures the eye’s ability to accommodate by responding to its natural signal to focus without spectacle dependence.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Undisclosed
Tracked Since
Nov 6, 2026
Web & Domain Identity
Official Website
adaptilens.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised undisclosed · Series-A
fundraisingfox.com
- Capital Raise
Raised $18,000,000 · Series-A
startupintros.com
- Capital Raise
Raised $2,000,000 · Seed
startupintros.com
Investors & Backers
Investor firms and individual backers were not publicly disclosed in available round filings for Adaptilens.
Funding History
Series-A equity
· May 11, 2026
undisclosed fundraisingfox.com
Series-A equity
· Apr 1, 2024
$18,000,000 startupintros.com
Seed equity
· Nov 1, 2020
$2,000,000 startupintros.com
Founders & Leadership
Liane Clamen
Founder & CEO
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026